NEW JOURNAL STUDIES
Avastin may
reduce corneal neovascularization This chart review of 10
patients finds that after subconjunctival injections of bevacizumab (2.5
mg/0.1 mL), the density and extent of corneal neovascularization decreased
in seven patients over three months of follow-up. Image analysis
determined that the area covered by neovascularization as a percentage of
the total corneal area decreased by 29 percent from 14.8 percent to 10.5
percent. Researchers observed no change in corneal vessel centricity, and
no significant adverse events. Cornea, February 2008
Type and
duration of diabetes independently associated with higher OAG risk in
Latinos This evaluation of data from the Los Angeles
Latino Eye Study finds that the prevalence of open-angle glaucoma (OAG)
was 40 percent higher in participants with type 2 diabetes than in those
without type 2 diabetes. Trend analysis also revealed a higher risk of OAG
among those who had type 2 diabetes for 15 years or longer.
Ophthalmology, February 2008
Many NAION
patients initially present with near normal vision This
large cohort study followed the natural history of patients with
nonarteritic anterior ischemic optic neuropathy (NAION). It shows that 49
percent of eyes examined within two weeks of onset had almost normal
visual acuity (20/15 to 20/30), but they all had one or another type of
optic disc-related visual field defect. Visual acuity and visual fields
mainly improved or further deteriorated within six months, with no
significant change after that. Ophthalmology, February
2008
Positive
five-year outcomes for deep sclerectomy with SkGel This
large retrospective study followed patients with open angle glaucoma who
underwent deep sclerectomy with a SkGel reticulated hyaluronic acid
implant. Surgery was considered a complete success (IOP of 16 mm Hg or
less, without medications) in 67.50 percent of the three-year follow-up
group, and in 64.95 percent of the five-year follow-up group. Visual field
testing at follow-up visits found stable mean deviation and corrected
pattern standard deviation values. Journal of Glaucoma,
January/February 2008
Using
same-size donor and recipient trephines doesn’t appear to reduce myopia
after PK for keratoconus This retrospective study included
878 grafts for patients undergoing their first penetrating keratoplasty
(PK). There was no significant difference in long-term refraction between
patients who had same-size and oversize grafts for keratoconus.
Postoperative visual acuity and graft survival were also comparable
between the two groups; however, the same-size donor trephine group was
associated with an increased risk of postoperative wound leaking.
Ophthalmology, February 2008
Using MMC to
improve the success of pterygium surgery This large
retrospective chart review of primary pterygium finds that intraoperative
mitomycin C 0.02% (MMC) can reduce recurrence in direct conjunctival
closure (DCC) procedures. However, the beneficial effect of MMC was not so
marked when it was associated with a sliding conjunctival graft (SCG).
Recurrence rates were similar between SCG without MMC and DCC with MMC.
British Journal of Ophthalmology, February 2008
Back
to Top
ACADEMY NEWS
Registration
and housing for the ISRS/AAO meeting in Cancún, Mexico are now
open The meeting, Refractive and Cataract Surgery:
Today and Tomorrow, will take place May 29 to 31, 2008, at the Fiesta
Americana Grand Coral Beach Cancún. This program includes many
cutting-edge educational sessions. Registration is free to ISRS/AAO
members. The deadline to register is April 16.
Academy publications earn high scores in industry
rankings Ophthalmology and EyeNet Magazine
have again maintained high readership ratings over the past year. In the
2007 Perq/HCI Media-Chek Eyecare study, Ophthalmology ranked
first among all publications for high readership, while EyeNet
ranked first among non-peer-reviewed publications. These scores reflect
how thoroughly and frequently ophthalmologists read these publications.
The Academy's Web site was named first among the most useful research
sites by 24 percent of all ophthalmologists surveyed, more than double the
responses for PubMed, its nearest competitor.
Back
to Top
|